cancer chemo (side-effect)

47 papers

• Ru-Based NSAIDs as Potential Anticancer Therapeutics.
  2026 ・ Molecules ・ PMID 41752368
  in vitro positive in vitro study
• Electrolyzed Hydrogen Water Improves Chemosensitivity to Anticancer Drugs by Potently Suppressing Autophagy.
  2026 ・ J Cell Mol Med ・ PMID 41702867
  in vitro positive in vitro study
• Four-dimensional data independent acquisition proteomics and metabolomics reveal mechanisms of hydrogen-rich water at Zusanli (ST36) point against triple-negative breast cancer in mice.
  2025 ・ J Tradit Chin Med ・ PMID 41376217
  injection / infusion positive animal study
• Clinical Efficacy of Hydrogen Therapy on Acute Radiation Enteritis and Inflammatory Response in Patients with Cervical Cancer Undergoing Concurrent Chemoradiation Therapy.
  2025 ・ Adv Radiat Oncol ・ PMID 41020280
  inhalation positive human randomized controlled trial
• Nanobiocatalyst-Driven Spatiotemporal Hydrogen Delivery Induces Dormancy Potentiated Catalytic Tumor Therapy.
  2025 ・ ACS Nano ・ PMID 40931918
  in vitro positive in vitro study
• Preventing Cisplatin-Induced Neuropathy and Related Emotional Disorders with the Coadministration of Duloxetine and Hydrogen-Rich Water in Male and Female Mice.
  2025 ・ Antioxidants (Basel) ・ PMID 40867900
  mixed routes positive animal study
• Local Delivery of Molecular Hydrogen by Fluorinated Zeolitic Imidazole Framework Nanosheets Boosts Cancer Immunotherapy.
  2025 ・ ACS Appl Mater Interfaces ・ PMID 40864154
  in vitro positive in vitro study
• Integrating QSAR modeling, ADMET screening, molecular docking, and molecular dynamics simulations to identify potential MCF-7 inhibitors.
  2025 ・ Comput Biol Med ・ PMID 40850177
  in vitro positive in vitro study
• Molecular hydrogen attenuates cisplatin-induced nephrotoxicity by modulating β-hydroxybutyrate metabolism.
  2025 ・ Mol Biol Rep ・ PMID 40705191
  inhalation positive animal study
• Long-term administration of hydrogen-rich water enhances quality of life in diabetic rats and reduces renal neoplasm incidence through modulation of inflammatory and metabolic pathways.
  2025 ・ Transl Androl Urol ・ PMID 40687659
  hydrogen-rich water positive animal study
• Molecular hydrogen as a novel regulator of cellular pyroptosis: mechanistic insights and therapeutic implications.
  2025 ・ Mol Biol Rep ・ PMID 40569354
  not specified not assessed review
• Molecular hydrogen as a potential mediator of the antitumor effect of inulin consumption.
  2025 ・ Sci Rep ・ PMID 40181080
  mixed routes positive animal study
• Engineering probiotic biohydrogen micro-factories to initiate reductive stress for boosting tumor vulnerability.
  2025 ・ Biomaterials ・ PMID 39426122
  in vitro positive in vitro study
• Molecular Hydrogen Protects against Various Tissue Injuries from Side Effects of Anticancer Drugs by Reducing Oxidative Stress and Inflammation.
  2024 ・ Biomedicines ・ PMID 39062164
  mixed routes not assessed review
• The Combination of Molecular Hydrogen and Heme Oxygenase 1 Effectively Inhibits Neuropathy Caused by Paclitaxel in Mice.
  2024 ・ Antioxidants (Basel) ・ PMID 39061924
  hydrogen-rich water positive animal study
• Prospects of molecular hydrogen in cancer prevention and treatment.
  2024 ・ J Cancer Res Clin Oncol ・ PMID 38555538
  mixed routes not assessed review
• Identification ofas a Susceptibility Gene for Familial Non-Medullary Thyroid Carcinoma.
  2024 ・ Thyroid ・ PMID 38411500
  in vitro not assessed other
• The Inhibition Mechanism of Pancreatic Ductal Adenocarcinoma via LXR Receptors: A Multifaceted Approach Integrating Molecular Docking, Molecular Dynamics and Post-MD Inter-Molecular Contact Analysis.
  2023 ・ Asian Pac J Cancer Prev ・ PMID 38156844
  in vitro positive in vitro study
• A Novel Therapy for Cisplatin-Induced Allodynia and Dysfunctional and Emotional Impairments in Male and Female Mice.
  2023 ・ Antioxidants (Basel) ・ PMID 38136183
  hydrogen-rich water positive animal study
• Hydrogen therapy as a potential therapeutic intervention in heart disease: from the past evidence to future application.
  2023 ・ Cell Mol Life Sci ・ PMID 37269385
  mixed routes not assessed review
• A Systematic Review of Molecular Hydrogen Therapy in Cancer Management.
  2023 ・ Asian Pac J Cancer Prev ・ PMID 36708550
  mixed routes positive review
• New Treatment for the Cognitive and Emotional Deficits Linked with Paclitaxel-Induced Peripheral Neuropathy in Mice.
  2022 ・ Antioxidants (Basel) ・ PMID 36552595
  hydrogen-rich water positive animal study
• Molecular Hydrogen Inhibits Colorectal Cancer Growth via the AKT/SCD1 Signaling Pathway.
  2022 ・ Biomed Res Int ・ PMID 35528164
  mixed routes positive in vitro study
• Hydrogen-rich water exerts anti-tumor effects comparable to 5-fluorouracil in a colorectal cancer xenograft model.
  2022 ・ World J Gastrointest Oncol ・ PMID 35116114
  hydrogen-rich water positive animal study
• A confined crosslinking strategy towards an intelligent organosilica-micellar hybrid drug delivery system.
  2022 ・ Biomater Sci ・ PMID 34904973
  in vitro positive in vitro study